semaglutide and prostate cancer Targeting obesity, metabolic syndrome, cancer: GLP-1 agonists as emerging therapeutic agents | Discover Oncology Potential preventive properties of GLP-1

Wegovy is also used to lower the risk of cardiovascular problems, and to treat a serious liver condition called MASH

Long-term safety data still pending

Given the surging popularity of obesity management drugs in recent years, the FDA put out a warning singling out compounded GLP-1s, calling them risky for patients. The agency said it had received hundreds of reports of adverse events linked to compounded semaglutide (392) and tirzepatide (215) as of Nov

Manufactured with strict quality control measures, Ozempic is subject to rigorous FDA oversight, ensuring that every dose meets high standards of purity, potency, and consistency

It's the entire rhythm of your treatment